Simultaneous targeting of MyD88 and Nur77 as an effective approach for the treatment of inflammatory diseases


Myeloid differentiation primary response protein 88 (MyD88) has long been considered a central player in the inflammatory pathway. Recent studies clearly suggest that it is an important therapeutic target in inflammation. On the other hand, a recent study on the interaction between the orphan nuclear receptor (Nur77) and p38α, leading to increased… (More)
DOI: 10.2147/DDDT.S103393


14 Figures and Tables